SCHEMBL14499591

SCHEMBL14499591

CC(C)c1nc2cc(-c3ccc4c(-c5ccc6ccccc6c5)c5ccccc5c(-c5ccc6ccccc6c5)c4c3)ccc2n1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.44
CYP1A2 P05177 3/20 0.44
CRBN Q96SW2 1/20 0.39
PIK3CD O00329 2/20 0.37
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
PTGER4 P35408 1/20 0.37
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CYP2C9 P11712 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.34
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
MAPK10 P53779 1/20 0.34
KDR P35968 1/20 0.33
KDM4E B2RXH2 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
PDE7A Q13946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14499584 0.95 PDE10A (0.47) PDE10ACYP1A2CRBNPIK3CDPIK3CA
SCHEMBL24674409 0.89 PDE10A (0.44) PDE10ACYP1A2CRBNPIK3CDPIK3CA
SCHEMBL14499570 0.88 PDE10A (0.42) PDE10ACYP1A2CRBNPIK3CDPIK3CA
SCHEMBL24813338 0.86 ALDH1A1 (0.52) PDE10ACYP1A2PIK3CDPIK3CAMTOR
SCHEMBL2604825 0.85 CRBN (0.47) PDE10ACYP1A2CRBNPIK3CDPIK3CA
SCHEMBL24813337 0.84 PDE10A (0.38) PDE10ACYP1A2CRBNPIK3CAKCNH2
SCHEMBL2604838 0.84 CRBN (0.47) PDE10ACYP1A2CRBNPIK3CDPIK3CA
SCHEMBL13042855 0.84 PTGER4 (0.44) PIK3CDPIK3CAMTORPTGER4ALDH1A1
SCHEMBL29444789 0.84 PTGER4 (0.44) PIK3CDPIK3CAMTORPTGER4ALDH1A1
SCHEMBL14499583 0.83 PDE10A (0.40) PDE10ACYP1A2CRBNPTGER4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070138950-A1 NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-21 US disclosed
US-20070138950-A1 NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070138950-A1 NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME EHD1, HCN2, ODC1 PDE10A 1885/4885CYP1A2 1906/4885CRBN 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.